- World rank, all time
- #32,898 of 34,923
- Rank in United States
- #6,905 of 7,310
- Research works
- 131 ▼ 62% vs 2018-21
- Citations
- 5.5k 42.4 per fractional work
- Top-10% rate
- 8.3% all institutions 10.0%
- vs its own fields
- 1.05× 1.00× is exactly expected
- Open access
- 46% world 40%
- International
- 20% world 18%
Which fields of science does ChemoCentryx (United States) work in?
In all years, 62% of research at ChemoCentryx (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (61%), Immunology and Microbiology (23%), Biochemistry, Genetics and Molecular Biology (9%). It does 2.5× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 18 fields, with their numbers
- Health Sciences8161.7%
- Medicine8061.3%
- Health Professions00.2%
- Nursing00.1%
- Dentistry00.1%
- Life Sciences4433.5%
- Physical Sciences64.4%
- Engineering21.4%
- Computer Science21.3%
- Chemistry10.8%
- Physics and Astronomy10.6%
- Materials Science00.3%
- Environmental Science00.1%
- Social Sciences10.4%
- Social Sciences00.2%
- Psychology00.1%
- Economics, Econometrics and Finance00.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.9×. Every wedge is a field page.
All 10 fields, with their numbers
- Immunology and Microbiology10.87×2 works
- Medicine3.46×10 works
- Physics and Astronomy1.27×0 works
- Biochemistry, Genetics and Molecular Biology0.94×1 works
- Dentistry0.89×0 works
- Computer Science0.78×1 works
- Materials Science0.62×0 works
- Engineering0.34×1 works
- Economics, Econometrics and Finance0.25×0 works
- Health Professions0.16×0 works
Who are the top researchers at ChemoCentryx (United States)?
Ranked on the quality score, Thomas J. Schall, Huibin Yue and Pirow J. Bekker lead among researchers whose main affiliation is ChemoCentryx (United States).
- 1
Thomas J. Schall
United States · #35,125 worldwide 32k citations · 268 works
- 2
Huibin Yue
United States · #169,035 worldwide 3k citations · 88 works
- 3
Pirow J. Bekker
United States · #264,249 worldwide 8.4k citations · 118 works
- 4
Mark E.T. Penfold
United States · #307,315 worldwide 5.3k citations · 47 works
- 5
Daniel J. Dairaghi
United States · #326,423 worldwide 3.4k citations · 44 works
- 6
Zhenhua Miao
United States · #620,530 worldwide 3.4k citations · 55 works
- 7
Penglie Zhang
United States · #732,512 worldwide 2.1k citations · 74 works
- 8
Robert Berahovich
United States · #892,273 worldwide 1.7k citations · 37 works
- 9
Dale Newland
United States · #935,093 worldwide 1.4k citations · 21 works
- 10
Juan C. Jaén
United States · #989,106 worldwide 4.6k citations · 160 works
Which keywords describe research at ChemoCentryx (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Angiogenesis, Therapeutic Targets, Immune Responses, Cell Migration, Host Defense, Cancer Metastasis and Chemokine Receptors.
- Metastasis
- Immune System
- Regulatory T Cells
- Fc Receptors
- Activation
- Monoclonal Antibodies
- Rituximab
- Vaccine Adjuvants
- PD-1 and PD-L1
- Antigen Presentation
- NK Cell Recognition
- Immunotherapy
- Genetics
- Cancer Immunotherapy
- Innate Immunity
- Tumor Microenvironment
- Chemokine Receptors
- Host Defense
- Immune Responses
- Angiogenesis
- Inflammation
- Therapeutic Targets
- Cell Migration
- Cancer Metastasis
- Cancer
- Immunity
- TGF-ß
- Immune Response
- Dendritic Cells
- Glycosylation
- Natural Killer Cells
- Immune Checkpoint Blockade
- Tumor Antigen
- Chemotherapy
- Metabolism
- Therapeutic Antibodies
- Antibody Engineering
- Macrophage
- Autoimmunity
- Thrombosis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation36▲ 12×31 topics
- Angiogenesis19▲ 35×6 topics
- Therapeutic Targets17▲ 57×5 topics
- Immune Responses17▲ 133×2 topics
- Cell Migration16▲ 144×2 topics
- Host Defense16▲ 188×3 topics
- Cancer Metastasis16▲ 380×1 topic
- Chemokine Receptors16▲ 759×1 topic
- Cancer12▲ 6.4×12 topics
- Tumor Microenvironment11▲ 23×7 topics
- Immunity10▲ 23×4 topics
- Innate Immunity9▲ 21×6 topics
- TGF-ß6▲ 29×3 topics
- Cancer Immunotherapy6▲ 33×3 topics
- Immune Response6▲ 7.3×8 topics
- Genetics6▲ 5.8×5 topics
- Dendritic Cells6▲ 38×2 topics
- Immunotherapy6▲ 6.7×10 topics
- Glycosylation6▲ 19×2 topics
- NK Cell Recognition6▲ 41×1 topic
- Natural Killer Cells6▲ 41×1 topic
- Antigen Presentation5▲ 40×2 topics
- Immune Checkpoint Blockade5▲ 71×1 topic
- PD-1 and PD-L15▲ 71×1 topic
- Tumor Antigen5▲ 48×1 topic
- Vaccine Adjuvants5▲ 48×1 topic
- Chemotherapy5▲ 5.1×10 topics
- Rituximab5▲ 22×4 topics
- Metabolism5▲ 5.5×3 topics
- Monoclonal Antibodies5▲ 24×3 topics
- Therapeutic Antibodies4▲ 26×2 topics
- Activation4▲ 93×1 topic
- Antibody Engineering4▲ 33×1 topic
- Fc Receptors4▲ 33×1 topic
- Macrophage4▲ 58×1 topic
- Regulatory T Cells4▲ 28×4 topics
- Autoimmunity4▲ 14×4 topics
- Immune System4▲ 9.2×3 topics
- Thrombosis3▲ 12×3 topics
- Metastasis3▲ 7.5×6 topics
Which research topics does ChemoCentryx (United States) publish most on?
By volume in 2022-now: Cancer Immunotherapy and Biomarkers, Vasculitis and related conditions, Renal Diseases and Glomerulopathies and Hidradenitis Suppurativa and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 2 Vasculitis and related conditions Pulmonary and Respiratory Medicine 1 works
- 3 Renal Diseases and Glomerulopathies Nephrology 1 works
- 4 Hidradenitis Suppurativa and Treatments Dermatology 1 works
- 5 Chronic Kidney Disease and Diabetes Nephrology 1 works
- 6 Colorectal and Anal Carcinomas Surgery 1 works
- 7 Complement system in diseases Immunology 1 works
- 8 Chemokine receptors and signaling Oncology 1 works
- 9 Otitis Media and Relapsing Polychondritis Rheumatology 0 works
- 10 CAR-T cell therapy research Oncology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has ChemoCentryx (United States)'s research output changed?
Output in 2022-2025 was 62% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is ChemoCentryx (United States) as a percentage of every work published that year, 0.000038% in 2024.
Fractional works of ChemoCentryx (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Mountain View
- Alphabet (United States)
- Creative Commons
- Synopsys (United States)
- Search for Extraterrestrial Intelligence
- Khan Academy
- Intuit (United States)
- NortonLifeLock (United States)
- Sequoia (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about ChemoCentryx (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
